| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 王斌 | 首创证券 | 医药生物 | 30.00% | 34.47% | 22.34% | 4.11% | 20 | -54.62% | 2025-07-17 |
| 2 | 华挺 | 财通证券 | 医药生物 | 29.94% | 34.13% | 7.56% | -6.67% | 6 | -50.33% | 2025-07-10 |
| 3 | 武煜 | 招银国际 | 医药生物 | 29.83% | 31.31% | 13.07% | -33.33% | 2 | -16.66% | 2025-05-23 |
| 4 | 武煜 | 招银国际 | 医药生物 | 29.83% | 29.39% | 12.45% | -33.33% | 2 | -16.66% | 2025-05-27 |
| 5 | 袁聪敏 | 中信证券 | 医药生物 | 29.80% | 23.53% | 25.84% | 100.00% | 5 | 0.00% | 2025-04-14 |
| 6 | 李安飞 | 广发证券 | 医药生物 | 29.78% | 27.48% | 35.71% | -2.86% | 1 | -56.96% | 2025-04-11 |
| 7 | 李安飞 | 广发证券 | 医药生物 | 29.78% | 25.20% | 27.03% | -2.86% | 1 | -56.96% | 2025-04-14 |
| 8 | 武煜 | 招银国际 | 医药生物 | 29.75% | 32.63% | 11.22% | -33.33% | 2 | -16.66% | 2025-05-26 |
| 9 | 仰佳佳 | 申万宏源 | 医药生物 | 29.75% | 27.48% | 19.78% | 23.08% | 1 | -37.64% | 2025-06-03 |
| 10 | 吴春红 | 江海证券 | 医药生物 | 29.69% | 28.72% | 27.74% | 27.27% | 11 | -25.67% | 2025-04-17 |
| 11 | 阳景 | 浦银国际证券 | 医药生物 | 29.68% | 26.87% | 5.00% | 100.00% | 4 | 0.00% | 2025-06-23 |
| 12 | 唐寅灏 | 中信证券 | 医药生物 | 29.66% | 22.61% | 20.10% | 85.71% | 12 | -8.47% | 2025-05-26 |
| 13 | 仰佳佳 | 申万宏源 | 医药生物 | 29.62% | 33.53% | 34.79% | 23.08% | 4 | -37.64% | 2025-04-14 |
| 14 | 阳景 | 浦银国际证券 | 医药生物 | 29.62% | 38.77% | 8.01% | 100.00% | 4 | 0.00% | 2025-06-05 |
| 15 | 吴春红 | 江海证券 | 医药生物 | 29.61% | 14.58% | 13.48% | 27.27% | 7 | -25.67% | 2025-06-13 |
| 16 | 仰佳佳 | 申万宏源 | 医药生物 | 29.53% | 32.43% | 27.73% | 23.08% | 1 | -37.64% | 2025-05-09 |
| 17 | 万鹏辉 | 国海证券 | 医药生物 | 29.51% | 12.82% | 23.19% | 50.00% | 5 | -3.00% | 2025-06-09 |
| 18 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 29.50% | 58.48% | 26.19% | 12.50% | 1 | -27.10% | 2025-03-19 |
| 19 | 袁聪敏 | 中信证券 | 医药生物 | 29.49% | 23.23% | 26.90% | 100.00% | 5 | 0.00% | 2025-04-15 |
| 20 | 吴春红 | 江海证券 | 医药生物 | 29.46% | 19.01% | 27.12% | 27.27% | 11 | -25.67% | 2025-04-21 |